| Literature DB >> 34123881 |
Siddharth Sarkar1, Tanveer Kaur2, Piyush Ranjan2, Anamika Sahu3, Archana Kumari4.
Abstract
The COVID-19 pandemic has affected the global population significantly and has resulted in physiological, psychological, social, and behavioral changes among the individuals. The prominent mental health effects of COVID-19 on the general and clinical populations have been well recognized. The family physicians and primary care practitioners from various disciplines are likely to encounter patients who are experiencing psychological distress manifested in the form of anxiety, depression, stress, insomnia, increased substance use, or other symptoms. This narrative review is aimed to present a bird's eye view of the psychological impact of COVID-19 on the general population and the various tools that are used to evaluate them. Besides, we intend to suggest a set of tools/questionnaires that can be used by the family physicians and primary care practitioners for generating data on the psychological impact of this pandemic. Copyright:Entities:
Keywords: COVID-19; family physicians; primary care practitioners; psychological distress; psychometrics
Year: 2021 PMID: 34123881 PMCID: PMC8144778 DOI: 10.4103/jfmpc.jfmpc_2107_20
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Common psychological tools and scales being used for psychological assessment during COVID 19 pandemic
| Instrument | Merits | Demerits |
|---|---|---|
| Generalized Anxiety Disorder-7 (GAD-7): Measures generalized anxiety symptoms over the course of the last 2 weeks (7 items, 4-point Likert Scale meaning 0=never to 3=nearly every day). | Brief questionnaire Association with depression, self-esteem, life satisfaction and resilience. | Doesn’t include standard criterion measures to assess convergent and discriminant validity |
| The Depression, Anxiety, and Stress Scale -21 (DASS-21): A self-report questionnaire consists of 21 items, 7 items per subscale assessing depression, anxiety and stress. | Assesses stress, anxiety and depression using a single instrument. | Lack of full scalar invariance across some countries. Cut-off scores for diagnosis not robustly determined. |
| Patient Health Questionnaire-9 (PHQ-9): A self-administered screening tool for assessment of depression. | A brief questionnaire that focuses on the 9 diagnostic criteria for DSM-IV depressive disorders. | Telephonic validation and the time for patients to complete the PHQ-9 have not been determined. |
| The Impact of Event Scale-Revised: This is a 22-item scale which is rated on a 0 (not at all) to 4 (extremely) level. Scale scores are formed for the three subscales, which reflect intrusion (8 items), avoidance (8 items), and hyperarousal (6 items). | Retains an emphasis on assessing the basic phenomena of intrusion and avoidance. | Results may not generalize beyond individuals who have Experienced a serious life events/trauma.Does not clarify on the significant life events. |
| CoViD-19 Peritraumatic Distress Index (CPDI): A 24-item scale with content referring to anxiety, depression, specific phobias, cognitive change, avoidance and compulsive behaviour, physical symptoms and loss of social functioning in the past week. Items are rated on a 5-point scale ranging from 0 (‘not at all’) to 4 (‘extremely’). | Non-intrusive and can be administered online. It can be used for identification of vulnerable individuals early and offer them psychological intervention | Does not provide thresholds for different diagnoses. |
Screening to identify psychological distress due to COVID 19 pandemic
| Construct | Features | Sample questions |
|---|---|---|
| Depression | Pervasive and persistent sadness | ‘In the last 2 weeks, have you been feeling sad, depressed or hopeless all through the day’ |
| Anxiety | Feeling anxious | ‘Have you been feeling anxious, nervous or on the edge’ |
| Stress | Inability to cope with personal problems | ‘Do you find yourself unable to cope with your personal problems’ |
| Insomnia | Difficulty in falling asleep | ‘Do you find it difficult to fall asleep nowadays’ |
| Substance use | Increase in alcohol use, smoking and other drugs | ‘Are you consuming alcohol, tobacco or other drugs more frequently than previous’ |
suggested strategy for mental health evaluation of the general practice patients during COVID 19 pandemic
| Depression, Stress and Anxiety Scale (DASS-21) | 21 Questions to assess the depression, stress and anxiety among the patients |
|---|---|
| Sleep Quality | In the past few months, did you find any change in your sleep routine? |
| Alcohol/substance addiction | In the past few months, did you notice any increase in the consumption of alcohol? |
| Phobia | In the past few months, did you refrain yourself from going out even when it is very necessary? |
| Distress | In the past few months, did you feel tired out for no good reason? |
| Attention to media | In the past few months, did you feel that you have been constantly monitoring news or social media for COVID-19 updates? |